אולנזאפין דקסל 5 מ"ג

Country: Ísrael

Tungumál: hebreska

Heimild: Ministry of Health

Virkt innihaldsefni:

OLANZAPINE 5 MG

Fáanlegur frá:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC númer:

N05AH03

Lyfjaform:

TABLETS

Stjórnsýsluleið:

PER OS

Framleitt af:

DEXCEL LTD

Meðferðarhópur:

OLANZAPINE

Ábendingar:

Acute and maintenance treatment of schizophrenia. Olanzapine is indicated for the management of the manifestations of psychotic disorders. Olanzapine is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder: in patients whose manic episodes has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: the combination of olanzapine with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Leyfisdagur:

2012-05-01